Compounds > tyrosyl-arginyl-phenylalanyl-lysinamide
Page last updated: 2024-09-03

tyrosyl-arginyl-phenylalanyl-lysinamide and erythrosine

tyrosyl-arginyl-phenylalanyl-lysinamide has been researched along with erythrosine in 1 studies

Compound Research Comparison

Studies
(tyrosyl-arginyl-phenylalanyl-lysinamide)		Trials
(tyrosyl-arginyl-phenylalanyl-lysinamide)		Recent Studies (post-2010)
(tyrosyl-arginyl-phenylalanyl-lysinamide)		Studies
(erythrosine)		Trials
(erythrosine)		Recent Studies (post-2010) (erythrosine)
7401715,4831082,574

Protein Interaction Comparison

ProteinTaxonomytyrosyl-arginyl-phenylalanyl-lysinamide (IC50)erythrosine (IC50)
Genome polyprotein Zika virus1.7
large T antigenBetapolyomavirus macacae13.04

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berezowska, I; Chen, H; Chung, NN; Lemieux, C; Schiller, PW; Weltrowska, G1

Other Studies

1 other study(ies) available for tyrosyl-arginyl-phenylalanyl-lysinamide and erythrosine

ArticleYear
Type and location of fluorescent probes incorporated into the potent mu-opioid peptide [Dmt]DALDA affect potency, receptor selectivity and intrinsic efficacy.
    The journal of peptide research : official journal of the American Peptide Society, 2005, Volume: 65, Issue:6

    Topics: 2-Naphthylamine; Alanine; Animals; Dansyl Compounds; Fluoresceins; Fluorescent Dyes; Mice; Oligopeptides; ortho-Aminobenzoates; Receptors, Opioid, mu; Tyrosine

2005